# Church & Dwight Co Inc: Form 10-Q for the period ended Jun 30, 2017

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2017-08-03
- Accepted by EDGAR: Aug 3, 2017, 17:05 ET
- Period: 2017-06-30
- Accession: 0001564590-17-015230
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459017015230/chd-10q_20170630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459017015230/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-04-01 to 2017-06-30 | $410.4m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2017-01-01 to 2017-06-30 | $809.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2017-04-01 to 2017-06-30 | $16.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2017-01-01 to 2017-06-30 | $30.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-04-01 to 2017-06-30 | $156.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2017-01-01 to 2017-06-30 | $268.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-04-01 to 2017-06-30 | $123.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2017-01-01 to 2017-06-30 | $319.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-04-01 to 2017-06-30 | $9.3m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2017-01-01 to 2017-06-30 | $17.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-04-01 to 2017-06-30 | $43.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2017-01-01 to 2017-06-30 | $102.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-04-01 to 2017-06-30 | $72.9m | us-gaap:ProfitLoss |
| Net income | 6 months, 2017-01-01 to 2017-06-30 | $204.4m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2017-04-01 to 2017-06-30 | $0.29 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2017-01-01 to 2017-06-30 | $0.79 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-04-01 to 2017-06-30 | $0.29 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2017-01-01 to 2017-06-30 | $0.81 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-04-01 to 2017-06-30 | 255,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2017-01-01 to 2017-06-30 | 257,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months, 2017-01-01 to 2017-06-30 | $10.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2017-01-01 to 2017-06-30 | $95.7m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2017-01-01 to 2017-06-30 | $300.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-06-30 | $237.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-06-30 | $877.2m | us-gaap:AssetsCurrent |
| Total assets | at 2017-06-30 | $4.67bn | us-gaap:Assets |
| Current liabilities | at 2017-06-30 | $1.21bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-06-30 | $2.82bn | us-gaap:Liabilities |
| Long-term debt | at 2017-06-30 | $894.1m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | at 2017-06-30 | $629.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2017-06-30 | $1.85bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 31,060 characters.

### RESULTS OF OPERATIONS

#### Recent Developments

#### Water Pik, Inc. Acquisition

On July 17, 2017, the Company entered into a stock purchase agreement to acquire Water Pik, Inc. (“Waterpik”), the market leader in water-jet technology in both oral water flossers and replacement showerheads. The total purchase price, which is subject to adjustments based on the closing working capital of Waterpik and its subsidiaries, is estimated to be $1,033.0. Waterpik’s annual sales were approximately $265.0 for the trailing twelve months through June 30, 2017. The Company will finance the acquisition with the proceeds of an underwritten public offering of $1.425.0 aggregate principal amount of senior notes that was completed on July 25, 2017. Waterpik will be managed by the Consumer Domestic and Consumer International segments. Refer to Note 20 of the condensed consolidated financial statements for the period ended June 30, 2017 included in this Form 10-Q and our Current Report on Form 8-K filed on July 17, 2017 for additional information with respect to the acquisition of Waterpik.

#### International Pension Plan Termination

In 2016 the Company authorized the termination of international defined benefit pension plans under which approximately 336 participants, including 53 active employees, had accrued benefits. The Company completed the termination of this plan in the second quarter of 2017. In addition to plan assets, the Company made a one-time payment of $7.5 to purchase annuities for participants. The Company recorded a one-time SG&A expense of $39.2 ($31.5 after tax) in the Consumer International segment. This expense primarily included the effect of the additional cash payment required at settlement and pension settlement accounting rules which require accelerated recognition of actuarial losses that were to be amortized over the expected benefit lives of participants. As of June 30, 2017, the Company has no further obligations with respect to material defined benefit pension plans.

### Results of Operations

### Consolidated results

|  | Three Months Ended June 30, 2017 | Change vs. Prior Year | Three Months Ended June 30, 2016 |
| --- | ---: | ---: | ---: |
| **Net Sales** | **$898.0** | 2.3% | $877.4 |
| **Gross Profit** | **$410.4** | 0.6% | $408.0 |
| Gross Margin | **45.7%** | -80 basis points | 46.5% |
| **Marketing Expenses** | **$130.9** | 8.9% | $120.2 |
| Percent of Net Sales | **14.6%** | +90 basis points | 13.7% |
| **Selling, General & Administrative Expenses** | **$156.3** | 38.9% | $112.5 |
| Percent of Net Sales | **17.4%** | +460 basis points | 12.8% |
| **Income from Operations** | **$123.2** | -29.7% | $175.3 |
| Operating Margin | **13.7%** | -630 basis points | 20.0% |
| **Net income per share - Diluted** | **$0.29** | -32.6% | $0.43 |
|  | **Six Months Ended** | **Change vs.** | **Six Months Ended** |
|  | **June 30, 2017** | **Prior Year** | **June 30, 2016** |
| **Net Sales** | **$1,775.2** | 2.8% | $1,726.4 |
| **Gross Profit** | **$809.7** | 2.9% | $787.0 |
| Gross Margin | **45.6%** | 0 basis points | 45.6% |
| **Marketing Expenses** | **$221.7** | 4.2% | $212.7 |
| Percent of Net Sales | **12.5%** | +20 basis points | 12.3% |
| **Selling, General & Administrative Expenses** | **$268.7** | 22.4% | $219.5 |
| Percent of Net Sales | **15.1%** | +240 basis points | 12.7% |
| **Income from Operations** | **$319.3** | -10.0% | $354.8 |
| Operating Margin | **18.0%** | -260 basis points | 20.6% |
| **Net income per share - Diluted** | **$0.79** | -7.1% | $0.85 |

Diluted Net Income per share was $0.29 in the second quarter of 2017 as compared to $0.43 in the same period in 2016. Diluted Net Income per share was $0.79 in the first six months of 2017 as compared to $0.85 in the same period in 2016. In the second quarter of 2017, the Company settled an international defined benefit plan, resulting in a pre-tax charge recorded in selling, general and administrative expenses of $39.2 ($31.5 after tax or $0.12 per share). During the first quarter of 2017, the Company closed the previously announced sale of its chemical business in Brazil. As a result, a pre and post- tax charge of $3.5 was recorded ($1.3 in cost of goods sold and $2.2 in selling, general and administrative expenses). This equated to $0.01 per share. Also during the first quarter, the Company adopted a new accounting standard related to certain aspects of share-based payment awards to employees. This standard requires that any excess tax benefits related to share-based payment awards to employees be recorded as a reduction to income tax expense. Previously, this benefit was recorded in the stockholders’ equity section of the Balance Sheet. The amount recorded in the three and six months ended June 30, 2017 as a reduction to income tax expense was $2.4 ($0.01 per share) and $11.1 ($0.04 per share), respectively.

On August 4, 2016, the Company announced a two-for-one stock split of the Company’s common stock (“Common Stock”). The stock split was structured in the form of a 100% stock dividend, payable on September 1, 2016 to stockholders of record as of August 15, 2016. All applicable amounts in the consolidated financial statements and related disclosures have been retroactively adjusted to reflect the stock split.

#### Net Sales

Net sales for the quarter ended June 30, 2017 were $898.0, an increase of $20.6 or 2.3% as compared to the same period in 2016. Net sales for the six months ended June 30, 2017 were $1,775.2, an increase of $48.8 or 2.8% over the comparable six month period of 2016. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended June 30, 2017 | Six Months Ended June 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 6.2% | 4.5% |
| Pricing/Product mix | (4.4%) | (2.4%) |
| Foreign exchange rate fluctuations | (0.6%) | (0.6%) |
| Volume from acquired product lines (net of divestiture) (1) | 1.1% | 1.3% |
| **Net Sales increase** | **2.3%** | **2.8%** |

(1) On December 22, 2016, the Company acquired the ANUSOL and RECTINOL business (the “Anusol Acquisition”) from Johnson & Johnson, Inc. On January 17, 2017, the Company acquired the VIVISCAL business (the “Viviscal Acquisition”) from Lifes2Good Holdings Limited. On May 1, 2017, the Company acquired Agro BioSciences, Inc. (the “Agro Acquisition”). Net sales of these acquisitions are included in the Company’s results since the date of acquisition. In March 2017, the Company sold its chemical business in Brazil.

For the three months and six months ended June 30, 2017, the volume change reflects increased product sales in all three segments.

#### Gross Profit / Gross Margin

The Company’s gross profit was $410.4 for the quarter ended June 30, 2017, a $2.4 increase as compared to the same period in 2016. Gross margin decreased 80 basis points (“bps”) in the second quarter of 2017 compared to the same period in 2016, primarily due to unfavorable price/mix of 250 bps (primarily due to promotion and coupon costs), higher commodity costs of 30 bps, and the impact of unfavorable foreign exchange rates of 10 bps, partially offset by the impact of higher margins on acquired businesses representing 80 bps, favorable volume of 70 bps and cost improvement projects representing 60 bps. Gross profit was $809.7 for the six months ended June 30, 2017, a $22.7 increase compared to the same period of 2016. Gross margin for the first six months of 2017 and 2016 was 45.6%. Gross margin remained consistent for the first six months of 2017 compared to the same period in 2016, primarily due to unfavorable price/mix of 150 bps (primarily due to promotion and coupon costs), higher commodity costs of 30 bps, and the impact of unfavorable foreign exchange rates of 10 bps, partially offset by the impact of higher margins on acquired businesses representing 70 bps, favorable volume of 60 bps and cost improvement projects representing 60 bps.

#### Operating Expenses

Marketing expenses for the second quarter of 2017 were $130.9, an increase of $10.7 or 8.9% as compared to the same period in 2016. Marketing expenses as a percentage of net sales in the second quarter of 2017 increased 90 bps to 14.6% as compared to 13.7% in 2016 due to 120 bps on higher expenses partially offset by 30 bps of leverage on higher net sales. Marketing expenses for the first six months of 2017 were $221.7, an increase of $9.0 as compared to the same period in 2016. Marketing expenses as a percentage of net sales for the six months of 2017 increased by 20 bps to 12.5% as compared to 12.3% in 2016 due to 50 bps on higher expenses partially offset by 30 bps of leverage on higher net sales.

Selling, general and administrative (“SG&A”) expenses were $156.3 in the second quarter of 2017, an increase of $43.8 or 38.9% as compared to the same period in 2016 primarily due to a $39.2 international pension settlement charge or 440 bps in 2017 and transition and ongoing costs associated with the Viviscal Acquisition, the Anusol Acquisition, and the Agro Acquisition. SG&A as a percentage of net sales increased 460 bps to 17.4% in the second quarter of 2017 as compared to 12.8% in the same period in 2016. The increase is due to higher costs, including pension settlement expense of 490 bps, partially offset by 30 bps of leverage associated with higher sales. SG&A for the first six months of 2017 was $268.7, an increase of $49.2 as compared to the same period in 2016. The increase is primarily due to the $39.2 international pension settlement charge or 220 bps in 2017, transition and ongoing acquisition-related costs, higher information costs and costs associated with selling its chemical business in Brazil. SG&A as a percentage of net sales increased 240 bps to 15.1% in the first six months of 2017 compared to 12.7% in 2016 due to higher costs, including pension settlement expense, of 280 bps partially offset by 40 bps of leverage associated with higher sales.

#### Other Income and Expenses

Equity in earnings of affiliates for the three and six month periods ended June 30, 2017 increased by $0.6 and $1.0 as compared to the same period in 2016, primarily due to profit improvement from Armand Products due to lower raw material costs.

Other expense, net for the three months ended June 30, 2017 increased $0.4 compared to the same period in 2016 primarily due to the effect of changes in foreign exchange rates and decreased $1.1 for the six months ended June 30, 2017 compared to the same period in 2016 due to the impact of costs incurred in 2016 associated with the Natronx Technologies, LLC (“Natronx”) joint venture.

Interest expense for the three and six month periods ended June 30, 2017 increased $2.2 and $3.6 as compared to the same periods in 2016 due to a higher amount of average debt outstanding and increased borrowing costs due to an increase in short-term interest rates.

#### Income Taxes

The effective tax rate for the three months ended June 30, 2017 was 37.6% compared to 34.7% in the same period in 2016. The increase in the tax rate is primarily due to an international pension settlement charge representing 450 bps, partially offset by a tax benefit of 200 bps related to the adoption of the new accounting standard which modifies how companies account for certain aspects of share-based payment awards to employees. Previously, this tax benefit was accounted for in the Company’s Stockholders’ Equity section of the Balance Sheet. Starting in 2017, the tax benefit is accounted for as a reduction of income tax expense.

The effective tax rate for the six months ended June 30, 2017 was 33.4% compared to 34.7% in the same period in 2016. The decrease in the tax rate is primarily due to the impact of the new accounting standard relating to share based payment awards representing 360 bps, partially offset by the international pension settlement charge representing 150 bps.

### Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings of affiliates. As of June 30, 2017, the Company held 50% ownership interests in each of Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings of Armand and ArmaKleen for the three and six month periods ended June 30, 2017 and 2016 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three and six month periods ended June 30, 2017 and June 30, 2016 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate(3) | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Second Quarter 2017** | **$678.2** | **$145.1** | **$74.7** | **$0.0** | **$898.0** |
| Second Quarter 2016 | 669.8 | 136.4 | 71.2 | 0.0 | 877.4 |
| **First Six Months of 2017** | **$1,337.9** | **$288.2** | **$149.1** | **$0.0** | **$1,775.2** |
| First Six Months of 2016 | 1,317.6 | 263.8 | 145.0 | 0.0 | 1,726.4 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **Second Quarter 2017(3)** | **$123.7** | **$(23.7)** | **$13.7** | **$3.1** | **$116.8** |
| Second Quarter 2016 | 141.6 | 16.2 | 10.7 | 2.5 | 171.0 |
| **First Six Months of 2017(3)** | **$284.6** | **$(4.3)** | **$21.5** | **$5.2** | **$307.0** |
| First Six Months of 2016 | 281.5 | 34.3 | 24.0 | 4.2 | 344.0 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $1.3 and $1.0 for the three months ended June 30, 2017 and June 30, 2016, respectively, and were $2.7 and $2.0 for the six months ended June 30, 2017 and June 30, 2016, respectively.

(2) In determining Income before Income Taxes, interest expense and investment earnings were allocated among the segments based upon each segment’s relative Income from Operations.

(3) Includes a pension settlement charge of $39.2 recorded in Consumer International.

Product line revenues from external customers are as follows:

|  | Three Months Ended June 30, 2017 | June 30, 2016 | Six Months Ended June 30, 2017 | June 30, 2016 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$410.8** | $397.8 | **$805.3** | $786.1 |
| Personal Care Products | **267.4** | 272.0 | **532.6** | 531.5 |
| Total Consumer Domestic | **678.2** | 669.8 | **1,337.9** | 1,317.6 |
| Total Consumer International | **145.1** | 136.4 | **288.2** | 263.8 |
| Total SPD | **74.7** | 71.2 | **149.1** | 145.0 |
| **Total Consolidated Net Sales** | **$898.0** | $877.4 | **$1,775.2** | $1,726.4 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the second quarter of 2017 were $678.2, an increase of $8.4 or 1.3% as compared to the same period in 2016. Consumer Domestic net sales for the six months ended June 30, 2017 were $1,337.9, an increase of $20.3 or 1.5% as compared to the same period in 2016. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended June 30, 2017 | Six Months Ended June 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 6.2% | 3.7% |
| Pricing/Product mix | (6.3%) | (3.4%) |
| Volume from acquired product lines (1) | 1.4% | 1.2% |
| **Net Sales increase** | **1.3%** | **1.5%** |

23

(1) Includes net sales of the brands acquired in the Viviscal Acquisition since the date of acquisition.

The increase in net sales for the three months ended June 30, 2017, reflects higher sales of ARM & HAMMER liquid and unit dose detergents, OXICLEAN laundry detergent and stain fighters, ARM & HAMMER cat litter, and BATISTE dry shampoo, partially offset by lower sales of TROJAN condoms, XTRA laundry detergent and FIRST RESPONSE pregnancy test kits. The increase in net sales for the six month period ending June 30, 2017, reflects higher sales of ARM & HAMMER liquid and unit dose detergents, BATISTE dry shampoo, OXICLEAN laundry detergent and stain fighters, and ARM & HAMMER cat litter, partially offset by lower sales of TROJAN condoms and XTRA laundry detergent.

There continues to be significant product and price competition in the laundry detergent category. For example, the Procter & Gamble Company markets a lower-priced line of laundry detergents that competes directly with the Company’s core value laundry detergents. Henkel AG & Co. KGaA (“Henkel”) entered the U.S. market with Persil, its leading worldwide premium laundry detergent, and in 2016 acquired The Sun Products Corporation (“Sun Products”), the maker of ALL, WISK and SUN laundry detergents. These actions have increased price competition and distribution pressures in the premium and extreme value laundry categories and could adversely impact sales and market share of the Company’s laundry brands. The Company continues to evaluate and vigorously combat these pressures through, among other things, new product introductions, increased marketing and trade spending.

Consumer Domestic income before income taxes for the second quarter of 2017 was $123.7, a $17.9 decrease as compared to the second quarter of 2016. The decrease is due primarily to unfavorable price/mix (in part due to higher promotional spending) of $42.9, higher marketing expenses of $9.2, and higher interest expense of $1.7, partially offset by the impact of higher sales volumes of $30.4, and favorable manufacturing costs of $6.1. For the six month period ended June 30, 2017, income before income taxes was $284.6, a $3.1 increase as compared to the first six months of 2016. The increase is due primarily to the impact of higher sales volumes of $40.3, favorable manufacturing costs of $16.8 and lower SG&A costs of $2.9, partially offset by unfavorable price/mix of $47.5, higher marketing expenses of $5.7 and higher interest expense of $3.1.

### Consumer International

Consumer International net sales were $145.1 in the second quarter of 2017, an increase of $8.7 or 6.4% as compared to the same period in 2016. Consumer International net sales in the first six months of 2017 were $288.2, an increase of $24.4 or approximately 9.2% as compared to the same period in 2016. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended June 30, 2017 | Six Months Ended June 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 6.8% | 9.7% |
| Pricing/Product mix | 0.6% | (0.2%) |
| Foreign exchange rate fluctuations / Other | (4.4%) | (4.0%) |
| Volume from acquired product lines (1) | 3.4% | 3.7% |
| **Net Sales increase** | **6.4%** | **9.2%** |

(1) Includes net sales of the brands acquired in the Anusol Acquisition and the Viviscal Acquisition since the date of acquisition.

Excluding the impact of unfavorable foreign exchange rates, higher sales in the second quarter ended June 30, 2017 were primarily due to FEMFRESH and BATISTE in the export business, ARM & HAMMER liquid laundry detergent, STERIMAR and OXICLEAN stain fighter gel in Mexico and BATISTE, VITAFUSION/L’IL CRITTERS and FEMFRESH in Australia. For the six months ended June 30, 2017 higher sales primarily occurred in exports, Canada, and Mexico, and were attributable to BATISTE, FEMFRESH, ARM & HAMMER liquid detergent, STERIMAR and ARM & HAMMER cat litter.

Consumer International loss before income taxes was $23.7 in the second quarter 2017, a decrease of $39.9 compared to the same period in 2016 due primarily to a pension settlement charge of $39.2, unfavorable manufacturing and commodity costs of $3.2, higher SG&A costs of $2.7, higher marketing costs of $2.6 and unfavorable foreign exchange rates of $2.2, partially offset by higher sales volumes of $9.3 and favorable price/mix of $1.4. For the first six months of 2017, loss before income taxes was $4.3, a $38.6 decrease as compared to the same period in 2016, due primarily to the pension settlement charge of $39.2, higher SG&A costs of $8.0, higher marketing costs of $5.3, unfavorable manufacturing and commodity costs of $3.6, unfavorable foreign exchange rates of $3.4, and unfavorable price/mix of $0.9, partially offset by higher sales volumes of $22.1.

### Specialty Products (“SPD”)

SPD net sales were $74.7 in the second quarter of 2017, an increase of $3.5 or 4.9% as compared to the same period in 2016. SPD net sales were $149.1 for the first six months of 2017, an increase of $4.1, or 2.8% as compared to the same period of 2016. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended June 30, 2017 | Six Months Ended June 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 5.6% | 1.7% |
| Pricing/Product mix | 3.8% | 2.7% |
| Foreign exchange rate fluctuations / Other | 0.0% | 0.6% |
| Volume from acquired product lines (net of divestiture) (1) | (4.5)% | (2.2)% |
| **Net Sales increase** | **4.9%** | **2.8%** |

(1) Includes net sales of the Agro Acquisition since the date of acquisition and is negatively impacted by the sale of the Brazilian chemical business.

The net sales increase in the second quarter and six month period of 2017 was driven primarily by improved price and volumes in the animal productivity business where milk prices and U.S. dairy farm profitability remain at a higher level than a year ago.

SPD income before income taxes was $13.7 in the second quarter of 2017, an increase of $3.0 as compared to the same period in 2016 due primarily to higher sales volume of $3.7, favorable price/product mix of $2.3, partially offset by higher manufacturing costs of $1.8 and higher SG&A costs of $1.5. SPD income before income taxes was $21.5 in the first six months of 2017, a decrease of $2.5 as compared to the same period in 2016 due primarily to higher manufacturing costs of $5.9, higher SG&A costs of $2.8 and costs associated with the sale of the Brazilian chemical business of $3.5, partially offset by higher sales volume of $3.6, favorable price/product mix of $3.6, lower costs associated with the Natronx joint venture of $1.5, lower marketing costs of $0.4 and favorable foreign exchange rates of $0.4.

### Corporate

The administrative costs of the Company’s production, planning and logistics functions are included in the SG&A expenses of each operating segment and as elements of cost of sales in the Company’s Condensed Consolidated Statements of Income. The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in the second quarter of 2017 and 2016. The Corporate segment income before income taxes was $3.1 in the second quarter of 2017, as compared to $2.5 in the same period in 2016. The Corporate segment income before income taxes was $5.2 for the first six months of 2017, as compared to $4.2 in the same period in 2016.

### Liquidity and Capital Resources

As of June 30, 2017, the Company had $237.6 in cash and cash equivalents, approximately $369 available through the revolving facility under its principal credit agreement (the “Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $600.0, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. On April 3, 2017, the Company’s $200.0 term loan facility was drawn upon in full to improve liquidity and pay a portion of the outstanding commercial paper. To preserve its liquidity, the Company invests its cash primarily in government money market funds, prime money market funds, short-term commercial paper and short-term bank deposits.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for the Company’s products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “Form 10-K”.) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenant in the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On February 7, 2017, the Board declared a 7% increase in the regular quarterly dividend from $0.1775 to $0.19 per share, equivalent to an annual dividend of $0.76 per share payable to stockholders of record as of February 21, 2017. The increase raises the annual dividend payout from $183 to approximately $195, and maintains the Company’s payout of dividends relative to net income at approximately 40%.

In connection with the Company’s share repurchase program authorized by the Board in November 2016 (the “2016 Share Repurchase Program”) and its evergreen repurchase program, the Company purchased approximately 6.0 million shares in the first six months of 2017 at a cost of approximately $300.0, of which approximately $125.0 was purchased under the evergreen share repurchase program and $175.0 was purchased under the 2016 Share Repurchase Program. The Company will continue its evergreen share repurchase program.

The Company anticipates that its cash from operations, together with its current borrowing capacity, will be sufficient to meet its capital expenditure program costs, which are expected to be a total of approximately $45.0 in 2017, fund its share repurchase programs to the extent implemented by management and pay dividends at the latest approved rate. Cash, together with the Company’s current borrowing capacity, may be used for acquisitions that would complement the Company’s existing product lines or geographic markets. The Company does not have any mandatory fixed rate debt principal payments in 2017.

The Company will finance the acquisition of Waterpik with a portion of the proceeds from an underwritten public offering of $1,425.0, aggregate principal amount of senior notes completed on July 25, 2017, consisting of $300.0 aggregate principal amount of Floating Rate Senior Notes due 2019, $300.0 aggregate principal amount of 2.450% Senior Notes due 2022, $425.0 aggregate principal amount of 3.150% Senior Notes due 2027 and $400.0 aggregate principal amount of 3.950% Senior Notes due 2047. The remaining proceeds were used to pay down in its entirety and terminate the Company’s $200.0 term loan and to repay a portion of the Company’s outstanding commercial paper borrowings.

#### Cash Flow Analysis

|  | Six Months Ended June 30, 2017 | June 30, 2016 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$249.3** | $296.5 |
| Net cash used in investing activities | **$(242.3)** | $(193.6) |
| Net cash provided by (used in) financing activities | **$33.2** | $(225.6) |

**Net Cash Provided by Operating Activities –** The Company’s primary source of liquidity is the strong cash flow provided by operating activities, which is dependent on the level of net income and changes in working capital. The Company’s net cash provided by operating activities in the six months ended June 30, 2017 decreased by $47.2 to $249.3 as compared to $296.5 in the same period in 2016 due to an increase in working capital, partially offset by higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, non-cash compensation and asset impairment charges). The change in working capital is primarily due to a large decrease in accounts payable and accrued expenses due to a change in deferred compensation, incentive compensation and profit sharing payments and larger increases in inventory and accounts receivable. However, the Company measures working capital effectiveness based on its cash conversion cycle. The following table presents the Company’s cash conversion cycle information for the quarters ended June 30, 2017 and 2016:

|  | As of June 30, 2017 | June 30, 2016 | Change |
| --- | ---: | ---: | ---: |
| Days of sales outstanding in accounts receivable ("DSO") | 31 | 29 | 2 |
| Days of inventory outstanding ("DIO") | 53 | 56 | (3) |
| Days of accounts payable outstanding ("DPO") | 67 | 60 | (7) |
| Cash conversion cycle | 17 | 25 | (8) |

The Company's cash conversion cycle (defined as the sum of DSO and DIO less DPO) which is calculated using a 2 period average method, improved 8 days from the prior year amount of 25 days to 17 days at June 30, 2017 due primarily to improved DPO of 7 days as the Company continues to extend payment terms with its suppliers. DIO improved 3 days from 56 to 53 days, offset by DSO which increased 2 days from 29 to 31 days. The improvement in the Company's cash conversion cycle reflects the Company's continued focus on reducing its average working capital requirements.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first six months of 2017 was $242.3, primarily reflecting $160.3 for the Viviscal Acquisition, $75.0 for the Agro Acquisition and $10.4 for property, plant and equipment expenditures, partially offset by $4.5 of cash proceeds from the sale of the Brazil chemical business. Net cash used in investing activities during the first six months of 2016 was $193.6, principally reflecting $175.5 for the Toppik Acquisition and $17.8 for property, plant and equipment expenditures.

**Net Cash Provided by (Used in) Financing Activities –** Net cash provided by financing activities during the first six months of 2017 was $33.2, primarily reflecting $207.2 of net commercial paper borrowings, $200.0 of long-term debt borrowings and $27.3 of proceeds from stock option exercises partially offset by $300.0 of repurchases of the Company’s Common Stock, $95.7 of cash dividend payments, and $4.6 of short-term debt repayments at an international subsidiary. Net cash used in financing activities during the first six months of 2016 was $225.6, primarily reflecting $200.0 of repurchases of the Company’s common stock and $91.7 of cash dividend payments, offset by $20.5 of commercial paper borrowings, $3.3 of short-term borrowings at an international subsidiary and $47.6 of proceeds and tax benefits from stock option exercises.

## Market risk

As filed, 346 characters.

### Market risk

For quantitative and qualitative disclosures about market risk affecting the Company, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. Our exposure to market risk has not changed materially since December 31, 2016.

## Controls and procedures

As filed, 5,038 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; sufficiency of cash flows from operations; earnings per share; the impact of new accounting pronouncements; cost savings programs; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of competitive laundry detergent products, including unit dose laundry detergent; the impact of foreign exchange and commodity price fluctuations; the Company’s investments in joint ventures; the impact of acquisitions and divestitures; the consummation, financing and impact of the Waterpik Acquisition; capital expenditures; pension settlement charges; the Company’s share repurchase programs and the Company’s effective tax rate. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; delays or other problems in manufacturing or distribution; adverse developments affecting the financial condition of major customers and suppliers; competition, including The Procter & Gamble Company’s participation in the value laundry detergent category and Henkel’s entry into the U.S. premium laundry detergent category; Henkel’s acquisition of Sun Products; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level acceptable to our customers and consumers; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; implications of the United Kingdom’s withdrawal from the European Union; issues relating to the Company’s information technology and controls; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed Aug 3, 2017.
Source: SEC EDGAR, the filing index for accession 0001564590-17-015230. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
